Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 19 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 657099 |
| 30 | 3 | INFECTIOUS DISEASES//MICROBIOLOGY//JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 113720 |
| 663 | 2 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY//ANTIMICROBIAL AGENTS AND CHEMOTHERAPY//CHEMOTHERAPY-TOKYO | 13777 |
| 11195 | 1 | CEFUROXIME AXETIL//CEFPODOXIME PROXETIL//CEFTIBUTEN | 1028 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | CEFUROXIME AXETIL | authKW | 361753 | 4% | 32% | 37 |
| 2 | CEFPODOXIME PROXETIL | authKW | 280261 | 2% | 38% | 24 |
| 3 | CEFTIBUTEN | authKW | 263526 | 2% | 36% | 24 |
| 4 | ORAL CEPHALOSPORIN | authKW | 217986 | 2% | 44% | 16 |
| 5 | CEFDINIR | authKW | 207711 | 2% | 28% | 24 |
| 6 | CEFPROZIL | authKW | 160145 | 2% | 33% | 16 |
| 7 | CEFACLOR | authKW | 152340 | 3% | 19% | 26 |
| 8 | CEFETAMET PIVOXIL | authKW | 150920 | 1% | 62% | 8 |
| 9 | LORACARBEF | authKW | 95496 | 1% | 35% | 9 |
| 10 | CEFETAMET | authKW | 83446 | 1% | 39% | 7 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Infectious Diseases | 9739 | 29% | 0% | 300 |
| 2 | Pharmacology & Pharmacy | 9229 | 55% | 0% | 563 |
| 3 | Microbiology | 6227 | 33% | 0% | 338 |
| 4 | Medicine, General & Internal | 376 | 10% | 0% | 106 |
| 5 | Medicine, Research & Experimental | 120 | 5% | 0% | 54 |
| 6 | Immunology | 107 | 7% | 0% | 69 |
| 7 | Chemistry, Analytical | 80 | 5% | 0% | 55 |
| 8 | Biochemical Research Methods | 28 | 3% | 0% | 28 |
| 9 | Oncology | 18 | 4% | 0% | 46 |
| 10 | Toxicology | 17 | 2% | 0% | 21 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | CHAIR CLIN HEMATOL INTENS THER Y | 30657 | 0% | 100% | 1 |
| 2 | DIP SCI MATERNOINFANTILI | 30657 | 0% | 100% | 1 |
| 3 | FARMACEUT TECNOL FARMACEUT | 30657 | 0% | 100% | 1 |
| 4 | MED AFFAIRS CLIN MED | 30657 | 0% | 100% | 1 |
| 5 | POST MKT SURVEILLANCE 1 | 30657 | 0% | 100% | 1 |
| 6 | SECT PEDIAT CLIN PHARMACOL EXPTL THER EUT | 30657 | 0% | 100% | 1 |
| 7 | SUBDIRECT GEN CIRUGIA | 30657 | 0% | 100% | 1 |
| 8 | WICHITA VAMC | 30657 | 0% | 100% | 1 |
| 9 | MAJEEDIA HOSP | 25078 | 0% | 27% | 3 |
| 10 | MODIFIED ANTIBIOT | 23216 | 0% | 15% | 5 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | JOURNAL OF DRUG DEVELOPMENT | 59110 | 1% | 21% | 9 |
| 2 | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 19338 | 12% | 1% | 124 |
| 3 | DRUG INVESTIGATION | 12683 | 1% | 4% | 11 |
| 4 | INFECTIOUS DISEASES IN CLINICAL PRACTICE | 11170 | 2% | 2% | 20 |
| 5 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 10344 | 6% | 1% | 66 |
| 6 | DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 9872 | 4% | 1% | 42 |
| 7 | INFECTION | 9252 | 3% | 1% | 34 |
| 8 | CLINICAL THERAPEUTICS | 8696 | 4% | 1% | 38 |
| 9 | CHEMOTHERAPY | 8694 | 3% | 1% | 27 |
| 10 | CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL | 5721 | 3% | 1% | 30 |
Author Key Words |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | CEFUROXIME AXETIL | 361753 | 4% | 32% | 37 | Search CEFUROXIME+AXETIL | Search CEFUROXIME+AXETIL |
| 2 | CEFPODOXIME PROXETIL | 280261 | 2% | 38% | 24 | Search CEFPODOXIME+PROXETIL | Search CEFPODOXIME+PROXETIL |
| 3 | CEFTIBUTEN | 263526 | 2% | 36% | 24 | Search CEFTIBUTEN | Search CEFTIBUTEN |
| 4 | ORAL CEPHALOSPORIN | 217986 | 2% | 44% | 16 | Search ORAL+CEPHALOSPORIN | Search ORAL+CEPHALOSPORIN |
| 5 | CEFDINIR | 207711 | 2% | 28% | 24 | Search CEFDINIR | Search CEFDINIR |
| 6 | CEFPROZIL | 160145 | 2% | 33% | 16 | Search CEFPROZIL | Search CEFPROZIL |
| 7 | CEFACLOR | 152340 | 3% | 19% | 26 | Search CEFACLOR | Search CEFACLOR |
| 8 | CEFETAMET PIVOXIL | 150920 | 1% | 62% | 8 | Search CEFETAMET+PIVOXIL | Search CEFETAMET+PIVOXIL |
| 9 | LORACARBEF | 95496 | 1% | 35% | 9 | Search LORACARBEF | Search LORACARBEF |
| 10 | CEFETAMET | 83446 | 1% | 39% | 7 | Search CEFETAMET | Search CEFETAMET |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |